Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill

Diagnostic Microbiology and Infectious Disease

Volumn 28, Issue 3, 1997, Pages 131-137

  Visalli, Melissa A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; BACTERIOLOGICAL TECHNIQUES; CIPROFLOXACIN; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 0030843042     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00017-5     Document Type: Article

References (28)

1. Appelbaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae - An overview. Clin Infect Dis 15:77-83.
2. Baquero F, Martínez-Beltrán J, Loza E (1991) A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 30 (suppl A):9-14.
3. Barry AL, Fuchs PC, Allen SD, Brown SD, Jorgensen JH, Tenover FC (1996) In-vitro susceptibility of Streptococcus pneumoniae to the d-and I-isomers of ofloxacin: Interpretive criteria and quality control limits. J Antimicrob Chemother 37:365-369.
4. Block S, Harrison CJ, Hedrick JA, Tyler RA, Smith E, Keegan E, Chartrand SA (1995) Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns, and antimicrobial management. Pediat Infect Dis J 14:751-759.
5. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR (1994) Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
6. Child J, Mortiboy D, Andrews JM, Chow AT, Wise R (1995) Open-label cross-over study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Antimicrob Agents Chemother 39:2749-2751.
7. Cormican MG, Jones RN (1995) Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and ofloxacin. Antimicrob Agents Chemother 33:215-216.
8. Doern GV, Brueggeman A, Holley HP Jr, Rauch AM (1996) Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 40:1208-1213.
9. Friedland IR, Istre GS (1992) Management of penicillin-resistant pneumococcal infections. Pediatr Infect Dis J 11:433-435.
10. Friedland IR, McCracken GH Jr (1994) Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 331:377-382.
11. Fu KP, Lafredo SC, Foleno B, Isaacson DM, Barrett JF, Tobia AJ, Rosenthale ME (1992) In vitro and in vivo antibacterial activities of levofloxacin (I-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 36:860-866.
12. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF (1995) The prevalence of drug resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 333:481-486.
13. Jacobs MR (1992) Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 15:119-127.
14. Jacobs MR, Appelbaum PC (1995) Antibiotic-resistant pneumococcci. Rev Med Microbiol 6:77-93.
15. Kam MM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM (1995) Emergence of multiple antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 39:2667-2670.
16. Klugman KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3:171-196.
17. Mason EO Jr, Kaplan SL, Lamberth LB, Tillman J (1992) Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 36:1703-1707.
18. McDougal LK, Facklam R, Reeves M, Hunter S, Swenson JM, Hill BC, Tenover FC (1992) Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother 36:2176-2184.
19. Munoz R, Musser JM, Crain M, Briles DE, Marton A, Parkinson AJ, Sorensen U, Tomasz A (1992) Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: Characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 15:112-118.
20. National Committee for Clinical Laboratory Standards (NCCLS) (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A4. Villanova, PA: NCCLS.
21. Nelson CT, Mason EO Jr, Kaplan SL (1994) Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: Implications for treatment. Pediatr Infect Dis J 13:585-589.
22. Neu HC, Chin N-X (1989) In vitro activity of S-ofloxacin. Antimicrob Agents Chemother 33:1105-1107.
23. Pankuch GA, Jacobs MR, Appelbaum PC (1994) Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob Agents Chemother 38:2065-2072.
24. Pankuch GA, Jacobs MR, Appelbaum PC (1995) Activity of CP 99,219 compared to DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin, and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 35:230-232.
25. Spangler SK, Jacobs MR, Appelbaum PC (1992) Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob Agents Chemother 36:856-859.
26. Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC (1993) Susceptibility of 170 penicillin-susceptible and -resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424, and RP 67829. J Antimicrob Chemother 31:273-280.
27. Sutton LD, Jones RN (1995) Suggested modifications for disk-diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates. Antimicrob Agents Chemother 33:146-148.
28. Visalli MA, Jacobs MR, Appelbaum PC (1996) MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 40: 362-366.